Venture Capital

A new campaign by Palvella Therapeutics and key partners aims to educate and empower patients with a rare disease, a strategic move ahead of a potential new drug.

A Black women-founded startup is betting on an invite-only, user-governed model to fix social media. Can exclusivity and community control dethrone the algorithm?

Embodied AI firm XGSynBot unveils its Z1 wheeled robot, designed for factory floors, not labs, aiming to solve manufacturing's 'automation paradox'.

A new cybersecurity firm backed by industry veterans has raised $125M to unleash autonomous AI agents that reason and act at machine speed.

Quantum firm Zapata adds industry veterans to its board, signaling a strategic shift in the quantum race from hardware supremacy to software application.

Telesat advances its Lightspeed network with new landing stations in Quebec and Saskatchewan, a key step in bridging the digital divide and competing in the LEO race.

With its novel glaucoma drug QLS-111 entering Phase 3, Qlaris Bio brings in seasoned leader Fred Guerard to navigate the final trials and path to market.

After two decades of building a global beauty empire, It's a 10 founder Carolyn Aronson is recognized among America's most dynamic women leaders.

Real estate tech firm RESAAS hires Oak Hill Financial, signaling a major push to enhance market visibility and attract investment amid a volatile stock history.

The alternative beverage market is booming with functional drinks. Discover how distributors like TruLife are the key link between innovation and your shopping cart.

Finance veteran Stephen Siderow brings institutional expertise to a burgeoning real estate tech VC, aiming to capitalize on AI-driven disruption.

With a new Chief Growth Officer and major investor backing, Guidelight Health is poised for aggressive expansion in the booming mental health care market.

Following a stock drop, SES AI launches a global tour to showcase its AI-driven battery tech, pivoting focus from EVs to energy storage and drones.

Middle and high schoolers are building AI to aid surgery and streamline recycling, signaling a major shift from college prep to real-world innovation.

Facing a labor crisis, Wilson James is deploying an AI platform to optimize operations and empower its workforce with flexible, transparent scheduling.

Alzheon's pill ALZ-801 shows promise in early AD patients with high genetic risk, offering a potential path that avoids the brain swelling seen in IV drugs.

After selling assets and raising cash, Q32 Bio focuses all its resources on bempikibart, a novel drug for hair loss, with pivotal data due in 2026.

As ATCO's Viva Homes aims to tackle the housing crisis, its new partnership with ComplyWorks embeds digital safety and compliance at the core of its strategy.

Eve Air Mobility, Alt Air, and Skyports team up to launch eVTOL services in NSW and Queensland, with an eye on the Brisbane 2032 Olympic Games.

Following a year of record growth, GovTech firm Esper lands new funding to expand its policy management platform, now serving 130 million Americans.